Thromb Haemost 1964; 11(01): 146-154
DOI: 10.1055/s-0038-1654815
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Tissue Extracts and their Sensitivity to Factor VII and Factor X

K. W. E Denson
1   Blood Coagulation Research Unit, Churchill Hospital, Headington, Oxford, Great Britain
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Summary

Lung thromboplastins made by conventional methods are normally heavily contaminated with factor VII, due to interaction of tissue with plasma or serum, and calcium during their preparation. Factor X is consumed during this process, and the resulting thromboplastin is capable of detecting deficiency of factor X in a plasma sample.

Lung thromboplastin may be prepared free from factor VII contamination, and such thromboplastin is extremely sensitive in detecting factor VII deficiency.

 
  • References

  • 1 Biggs R, Macfarlane R. G. Human Blood Coagulation and Its Disorders. Blackwell Scientific Publications; Oxford: 1962
  • 2 Denson K. W. The specific assay of Prower-Stuart Factor and Factor VII. Acta haemat 25: 105 1961;
  • 3 Denson K. W. Levels of blood coagulation factors during anticoagulant therapy with Phenindione. Brit. med. J I: 1205 1961;
  • 4 Montigel C. The mode of action of different thromboplastin preparations. Schweiz, med. Wschr 89: 1259 1959;
  • 5 Straub W, Duckert F. The formation of the extrinsic prothrombin activator. Thrombos. Diathes. haemorrh. (Stuttg) 05: 402 1961;
  • 6 Verstraete M, Clark P. A, Wright I. S. Evaluation of prothrombin time performed with different thromboplastins. Acta. med. scand 163: 105 1959;
  • 7 Weiß H. J, Eikelberger J. W, Crosby W. H. Study on the differences in activity of lung and brain thromboplastin. 40: 205 1960;